Delivery Order HHSN272201300002I-HHSN27200012
Award Date
9/1/15
Potential Completion Date
4/30/20
Potential Value
$318K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $3,780,242.42, is for the provision of Simian Vaccine Evaluation Units, which involves the development of vaccines and other medical countermeasures for infectious diseases. The...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS). The contract is for the Simian Vaccine Evaluation Units program and has a ceiling value of $1,510,348.00. The contract is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) contract for Simian Vaccine Evaluation Units between 2013-2020. The contract is a Cost...
This federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) is for the SIMIAN VACCINE EVALUATION UNITS program, with a ceiling value of $601,306.73. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), a civilian federal agency. The contract has no set-aside designation. ABL is a leading contract research and manufacturing organization that specializes in the development of vaccines, gene...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, titled "SIMIAN VACCINE EVALUATION UNITS," was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization specializing in the development of vaccines, biologics, and other medical countermeasures. The...
This federal contract award, valued at $462,454.57, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer. The contract is a Delivery Order under the Simian Vaccine Evaluation Units 2013-2020 Indefinite Delivery Vehicle (IDV), and the work involves providing administrative and technical support for ongoing Task Area 3 studies and final transition. The contract does not have...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL) for the "Simian Vaccine Evaluation Units" program. The award, with a ceiling value of $182,911.36, is a delivery order issued against ABL's existing Simian Vaccine Evaluation Units 2013-2020 indefinite-delivery/indefinite-quantity (IDIQ) contract. The contract does not...
This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for the "Simian Vaccine Evaluation Units" program. The contract has a ceiling value of $15,116,116.33 and a period of performance through September 9, 2023. This is a delivery order issued under a larger Simian Vaccine Evaluation Units 2013-2020 IDIQ (Indefinite...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $964,411.81, is for the Simian Vaccine Evaluation Units program, which supports the development of vaccines and countermeasures for infectious diseases. The contract does...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL) for the "Simian Vaccine Evaluation Units" program. The $3,605,430.51 cost-plus-fixed-fee contract does not have a set-aside designation and runs through September 9, 2023. It is part of a larger Simian Vaccine Evaluation Units 2013-2020...
This federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) is for the "SIMIAN VACCINE EVALUATION UNITS" program, which is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $2,833,961.28, is for cGMP manufacturing, testing, and other services to support the development of vaccines and other...